Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_provenance.
- befree-2016 importedOn "2016-02-19" NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_provenance.
- NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_assertion wasGeneratedBy ECO_0000203 NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_provenance.
- NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_assertion wasDerivedFrom befree-2016 NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_provenance.
- NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_assertion SIO_000772 17921715 NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_provenance.
- NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_assertion evidence source_evidence_literature NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_provenance.
- NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_assertion description "[COX-2 and NF-KB overexpression is common in pancreatic cancer but does not predict for COX-2 inhibitors activity in combination with gemcitabine and oxaliplatin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP634159.RADsq2whCqOHw5TOdNL4L6ccESq8WQ2tanSvS9dSdeC8I130_provenance.